LuCaBIS: A Burden of Illness Study in Stage IB-IIIA NSCLC Patients

• Research type

  Research Study

• Full title

  LuCaBIS: A Burden of Illness Study in Patients with Stage IB-IIIA Non–small Cell Lung Cancer (NSCLC)

• IRAS ID

  117859

• Contact name

  Penella J Woll

• Contact email

  p.j.woll@sheffield.ac.uk

• Sponsor organisation

  GlaxoSmithKline (GSK)

• REC name

  Yorkshire & The Humber - Sheffield Research Ethics Committee

• REC reference

  12/YH/0542

• Date of REC Opinion

  23 Jan 2013

• REC opinion

  Further Information Favourable Opinion